CytoMed Therapeutics Limited (NASDAQ:GDTC – Get Rating) saw a significant growth in short interest in May. As of May 31st, there was short interest totalling 62,600 shares, a growth of 67.8% from the May 15th total of 37,300 shares. Based on an average daily trading volume, of 185,500 shares, the short-interest ratio is presently 0.3 […]
CytoMed Therapeutics’ (NASDAQ:GDTC – Get Rating) quiet period is set to expire on Wednesday, May 24th. CytoMed Therapeutics had issued 2,412,369 shares in its IPO on April 14th. The total size of the offering was $9,649,476 based on an initial share price of $4.00. During the company’s quiet period, underwriters and any insiders involved in […]